SYFOVRE 5-Year GALE Analysis Shows ~1.5-Year Delay in GA Progression in Nonsubfoveal Disease
Five-year data extend structural benefits but highlight ongoing gaps in functional outcomes Long-term data in geographic atrophy (GA) is rare,…
Eli Lilly Expands Gene Therapy Portfolio to Eye Care with $475M MeiraGTx Deal
Eli Lilly bets big on the future of gene therapy for vision restoration. Eli Lilly is making another bold move…
popular posts
latest posts
